JP5523652B2 - Gel cosmetic and method for producing the same - Google Patents
Gel cosmetic and method for producing the same Download PDFInfo
- Publication number
- JP5523652B2 JP5523652B2 JP2006177362A JP2006177362A JP5523652B2 JP 5523652 B2 JP5523652 B2 JP 5523652B2 JP 2006177362 A JP2006177362 A JP 2006177362A JP 2006177362 A JP2006177362 A JP 2006177362A JP 5523652 B2 JP5523652 B2 JP 5523652B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- extract
- gel
- phospholipid
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 74
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 150000003904 phospholipids Chemical class 0.000 claims description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 230000002378 acidificating effect Effects 0.000 claims description 17
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 14
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 7
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000000284 extract Substances 0.000 description 78
- 239000000499 gel Substances 0.000 description 64
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 55
- -1 acyl sulfonate Chemical compound 0.000 description 32
- 229960000541 cetyl alcohol Drugs 0.000 description 27
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 23
- 239000000843 powder Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 230000007704 transition Effects 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 8
- 238000013329 compounding Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000007794 irritation Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 6
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 229960000735 docosanol Drugs 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 3
- 229940043276 diisopropanolamine Drugs 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229940009662 edetate Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940043348 myristyl alcohol Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 235000003130 Arctium lappa Nutrition 0.000 description 2
- 235000008078 Arctium minus Nutrition 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 235000020737 peppermint extract Nutrition 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- CTETYEBLODEFQI-UHFFFAOYSA-N 2-(2-hydroxyethylamino)ethanol;3-(4-methoxyphenyl)propanoic acid Chemical compound OCCNCCO.COC1=CC=C(CCC(O)=O)C=C1 CTETYEBLODEFQI-UHFFFAOYSA-N 0.000 description 1
- ZUAURMBNZUCEAF-UHFFFAOYSA-N 2-(2-phenoxyethoxy)ethanol Chemical compound OCCOCCOC1=CC=CC=C1 ZUAURMBNZUCEAF-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UQPLZHUFLPDORW-UHFFFAOYSA-N 2-phenylphenol;sodium Chemical compound [Na].OC1=CC=CC=C1C1=CC=CC=C1 UQPLZHUFLPDORW-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000004716 Ethylene/acrylic acid copolymer Substances 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- QWZLBLDNRUUYQI-UHFFFAOYSA-M Methylbenzethonium chloride Chemical compound [Cl-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 QWZLBLDNRUUYQI-UHFFFAOYSA-M 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000287462 Phalacrocorax carbo Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000020739 avocado extract Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000020691 dandelion extract Nutrition 0.000 description 1
- 229940067866 dandelion extract Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- CDIPRYKTRRRSEM-UHFFFAOYSA-M docosyl(trimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C CDIPRYKTRRRSEM-UHFFFAOYSA-M 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960002285 methylbenzethonium chloride Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940090668 parachlorophenol Drugs 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- SZEMGTQCPRNXEG-UHFFFAOYSA-M trimethyl(octadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C SZEMGTQCPRNXEG-UHFFFAOYSA-M 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Description
本発明は、ゲル状化粧料及びその製造方法に関し、さらに詳しくは、均一な外観を有し、刺激感、べたつきがなく、しっとり感、柔らかな皮膜感、経日安定性に優れたゲル状化粧料及びその製造方法に関するものである。 The present invention relates to a gel cosmetic and a method for producing the same, and more specifically, a gel cosmetic having a uniform appearance, having no irritation, stickiness, moist feeling, soft film feeling, and stability over time. The present invention relates to a material and a manufacturing method thereof.
従来、医薬品、化粧料において剤形保持及び感触向上のための増粘を目的として、様々なゲル状組成物が用いられてきた(例えば、特許文献1、2参照。)。しかし、これらゲル状組成物は、N−長鎖アシル酸性アミノ酸モノ塩や長鎖アシルスルホン酸塩型陰イオン性界面活性剤を含有しており、これらに特有の刺激感及びべたつき感が感じられ、柔らかな皮膜感を付与させることは困難であった。
Conventionally, various gel-like compositions have been used in pharmaceuticals and cosmetics for the purpose of thickening for maintaining the dosage form and improving the feel (see, for example,
また、最近では、刺激性が少なく使用感にも優れたリン脂質を用いたゲル状化粧料が提案されている(例えば、特許文献3、4参照。)。しかし、これらリン脂質を用いたゲル状化粧料も界面活性剤との組み合わせが多いため、刺激性が高くなり、又ぬめり感も増え、柔らかな皮膜感を付与させることは出来なかった。
Recently, gel-like cosmetics using phospholipids that are less irritating and excellent in usability have been proposed (see, for example,
一方、高級アルコールは、独特の感触、特に固体の高級アルコールの場合には固体特有の皮膜を形成させるため、これまでにも化粧料に配合されてきた。 On the other hand, higher alcohols have been blended in cosmetics so far in order to form a unique texture, particularly in the case of solid higher alcohols, a film specific to solids.
また、最近では、天然成分であるリン脂質を用いて化粧料を調製する試みもなされている。例えば、レシチンと常温で液状の高級アルコールとグリセリンを併用したクリームは、安全性が高く、肌への親和性、保湿性に優れた乳化化粧料が紹介されている(例えば、特許文献5参照。)。 Recently, attempts have been made to prepare cosmetics using phospholipids, which are natural ingredients. For example, a cream using a combination of lecithin, a higher alcohol that is liquid at room temperature and glycerin is highly safe, and emulsified cosmetics with excellent affinity for skin and moisture retention have been introduced (see, for example, Patent Document 5). ).
本発明はこのような従来の問題点を解決するためになされたもので、従来以上に、均一な外観を有し、刺激感が少なく、べたつきがなく、さらにしっとり感、柔らかな皮膜感、経日安定性に優れたゲル状化粧料を提供することを目的とするものである。 The present invention has been made to solve such conventional problems, and has a more uniform appearance, less irritation, no stickiness, more moist feeling, soft film feeling, and more An object of the present invention is to provide a gel cosmetic having excellent day stability.
本発明者は上記課題を解決すべく鋭意検討した結果、特定の水素添加リン脂質と、特定の高級アルコールと、水との相乗効果で形成された、これまでに報告されておらず本発明によって初めて明らかにされたゲルにより、従来以上に、刺激感、べたつきがなく、さらにしっとり感、柔らかな皮膜感に優れたゲル状化粧料が得られることを見い出し、本発明を完成させるに至った。 As a result of intensive studies to solve the above problems, the present inventor has formed a synergistic effect of a specific hydrogenated phospholipid, a specific higher alcohol, and water, and has not been reported so far. It has been found that a gel-like cosmetic with a gel that has been clarified for the first time has no irritation and stickiness, and has a moist and soft film feeling, and thus the present invention has been completed.
すなわち本発明は、成分(a)としてホスファチジルコリン含有量が70質量%以上、且つ酸性リン脂質含有量がホスファチジルコリン含有量に対して10質量%以上である水素
添加リン脂質、成分(b)として室温で固形である高級アルコール、成分(c)として水、及び成分(d)としてジプロピレングリコールを含有し、成分(a)水素添加リン脂質と成分(b)高級アルコールの比率が、モル比で1:2〜1:3であり、油含有量が3%未満であることを特徴とするゲル状化粧料である。
That is, the present invention provides a hydrogenated phospholipid having a phosphatidylcholine content of 70 % by mass or more as the component (a) and an acid phospholipid content of 10% by mass or more based on the phosphatidylcholine content, and a component (b) at room temperature. A higher alcohol that is solid, water as component (c), and dipropylene glycol as component (d), wherein the ratio of component (a) hydrogenated phospholipid to component (b) higher alcohol is 1: The gel cosmetic is characterized in that the ratio is 2 to 1: 3 and the oil content is less than 3%.
また、上記成分(a)水素添加リン脂質と上記成分(b)高級アルコールの総量が1〜15質量%であることが好ましい。 Moreover, it is preferable that the total amount of the said component (a) hydrogenated phospholipid and the said component (b) higher alcohol is 1-15 mass%.
また、本発明のゲル状化粧料は、粘度が25℃において、1000〜20000cpsであることが好ましい。 The gel cosmetic of the present invention preferably has a viscosity of 1000 to 20000 cps at 25 ° C.
また、本発明のゲル状化粧料は、pHが、6.0〜7.0であるあることが好ましい。 The gel cosmetic of the present invention preferably has a pH of 6.0 to 7.0 .
また、本発明のゲル状化粧料は、更に成分(e)としてカルボキシビニルポリマー及び/又はアルキル変性カルボキシビニルポリマーを含有することが好ましい。 The gel cosmetic of the present invention preferably further contains a carboxyvinyl polymer and / or an alkyl-modified carboxyvinyl polymer as component (e).
また、本発明のゲル状化粧料は、化粧料としての外観上、半透明状であることが好ましい。 Moreover, it is preferable that the gel-like cosmetics of this invention are translucent from the external appearance as cosmetics.
本発明によれば、均一な外観を有し、刺激感、べたつきがなく、さらにしっとり感、柔らかな皮膜感、経日安定性に優れたゲル状化粧料を提供できる。 ADVANTAGE OF THE INVENTION According to this invention, it can provide the gel-like cosmetics which have a uniform external appearance, do not have irritation feeling and stickiness, and are excellent in moist feeling, a soft film feeling, and stability over time.
以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明のゲル状化粧料において、成分(a)である水素添加リン脂質と、成分(b)である高級アルコールは、成分(c)である水中で会合体を形成し、この会合体が水相中に均一に分散することにより均一なゲルを形成することができる。 In the gel cosmetic of the present invention, the hydrogenated phospholipid as component (a) and the higher alcohol as component (b) form an aggregate in the water as component (c), and this aggregate is water. A uniform gel can be formed by uniformly dispersing in the phase.
上記成分(a)である水素添加リン脂質は、熱や酸化安定性が高く、ゲル形成能の高いものを用いる。すなわち、ホスファチジルコリン(以下、PCと称す。)を50質量%以上含有し、且つ酸性リン脂質をPC含有量に対して10質量%以上含有することを必須と
する水素添加リン脂質である。
The hydrogenated phospholipid which is the component (a) is one having high heat and oxidation stability and high gel forming ability. That is, it is a hydrogenated phospholipid containing phosphatidylcholine (hereinafter referred to as “PC”) in an amount of 50% by mass or more and containing an acidic phospholipid in an amount of 10% by mass or more based on the PC content.
上記成分(a)水素添加リン脂質におけるPC含量が50質量%未満の場合では、均一な分散状態にはなるものの、成分(b)高級アルコールとの会合体形成において増粘機構に乏しく十分なゲル構造は得られず、ゲル状の化粧料は得られない。従って、ゲル形成の観点から、均一な分散状態のゲル状化粧料と得るために、PC含有量としては50質量%以上が必要であり、より好ましくは60〜80質量%、さらに好ましくは65〜75質量%である。 In the case where the PC content in the component (a) hydrogenated phospholipid is less than 50% by mass, a uniform dispersion state is obtained. However, the gel is insufficient in the thickening mechanism in forming an association with the component (b) higher alcohol. No structure is obtained, and no gel-like cosmetic is obtained. Therefore, from the viewpoint of gel formation, in order to obtain a gel-like cosmetic material in a uniformly dispersed state, the PC content is required to be 50% by mass or more, more preferably 60 to 80% by mass, and still more preferably 65 to 65% by mass. 75% by mass.
さらに、上記成分(a)水素添加リン脂質における酸性リン脂質の含有量が、PC含有量に対して10質量%未満の場合でも、成分(b)高級アルコールとの会合体を水相に均一に分散することができず、凝集を起こし、均一なゲルは形成されない。従って、ゲル形成の観点から、均一な分散状態のゲル状化粧料を得るために、酸性リン脂質の含有量としては、成分(a)水素添加リン脂質におけるPC含有量に対する質量比として、10質量%以上が必要であり、10〜30質量%であるとより好ましい。 Further, even when the content of the acidic phospholipid in the component (a) hydrogenated phospholipid is less than 10% by mass with respect to the PC content, the association with the component (b) higher alcohol is made uniform in the aqueous phase. It cannot be dispersed, causes aggregation, and does not form a uniform gel. Therefore, from the viewpoint of gel formation, in order to obtain a gel cosmetic in a uniform dispersion state, the content of acidic phospholipid is 10 mass as the mass ratio to the PC content in component (a) hydrogenated phospholipid. % Or more is necessary, and it is more preferable in it being 10-30 mass%.
上記酸性リン脂質として具体的には、ホスファチジン酸、ホスファチジルセリン、ホスファチジルグリセロール、ホスファチジルイノシトール及びこれらのリゾ体が挙げられる。これらは、単独で成分(a)水素添加リン脂質に配合されていても良いが、これらの酸性リン脂質を含む大豆レシチン、卵黄レシチン等の群より選択することもできる。これらは、1種又は2種以上を組み合わせて使用することができる。 Specific examples of the acidic phospholipid include phosphatidic acid, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol, and lysates thereof. These may be blended alone in the component (a) hydrogenated phospholipid, but can also be selected from the group of soybean lecithin, egg yolk lecithin and the like containing these acidic phospholipids. These can be used alone or in combination of two or more.
本発明で用いられる上記成分(a)水素添加リン脂質は、通常化粧料原料として用いられるものであればよく、大豆、卵黄、トウモロコシ、ナタネ等の動植物、大腸菌等の微生物から抽出される天然のレシチンの水素添加物、並びに合成のレシチンの水素添加物が挙げられる。具体的には、大豆レシチン、卵黄レシチンの水素添加物、並びにホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルグリセロール、ホスファチジルイノシトール、スフィンゴリン脂質、ホスファチジン酸、リゾホスファチジルコリンの混合物等が挙げられる。この中で、化粧品原料として安定的に入手しやすいことから、水素添加大豆レシチンが最も好ましい。 The above-mentioned component (a) hydrogenated phospholipid used in the present invention is not limited as long as it is usually used as a raw material for cosmetics. Examples include lecithin hydrogenates, as well as synthetic lecithin hydrogenates. Specific examples include hydrogenated products of soybean lecithin and egg yolk lecithin, and mixtures of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol, sphingophospholipid, phosphatidic acid, lysophosphatidylcholine, and the like. Among these, hydrogenated soybean lecithin is the most preferable because it is easily available as a cosmetic raw material.
上記成分(a)水素添加リン脂質は、1種単独又は2種以上を組み合わせて化粧料に配合することができ、その配合量は、特に限定されないが、使用感及び保湿感の観点から、化粧料の総量を基準として、0.1〜10質量%が好ましく、特に好ましくは1〜5質量%である。 The component (a) hydrogenated phospholipid can be blended in cosmetics alone or in combination of two or more, and the blending amount is not particularly limited. 0.1 to 10% by mass is preferable, particularly 1 to 5% by mass, based on the total amount of the material.
本発明で用いられる成分(b)としての室温で固形である高級アルコールとしては、ゲル形成能及び使用感、保湿感の観点から、室温で固体であることを必須とする。ここでいう室温とは、20℃である。上記高級アルコールとして、好ましくは、ラウリルアルコール、ミリスチルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール等が挙げられ、最も好ましくはセチルアルコールである。またこれらの高級アルコールは1種単独又は2種以上を組み合わせて用いることができる。 The higher alcohol that is solid at room temperature as the component (b) used in the present invention must be solid at room temperature from the viewpoint of gel forming ability, feeling of use, and moisturizing feeling. Room temperature here is 20 degreeC. Preferred examples of the higher alcohol include lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, and behenyl alcohol. Most preferred is cetyl alcohol. These higher alcohols can be used singly or in combination of two or more.
上記成分(b)高級アルコールは、特に限定されないが、使用感の観点から、化粧料の総量を基準として、0.1〜10質量%が好ましく、さらに好ましくは1〜5質量%である。 Although the said component (b) higher alcohol is not specifically limited, From a viewpoint of usability, 0.1-10 mass% is preferable on the basis of the total amount of cosmetics, More preferably, it is 1-5 mass%.
本発明のゲル状化粧料における成分(a)水素添加リン脂質と、成分(b)高級アルコール及び成分(c)水とによる会合体の形成は、水素添加リン脂質と高級アルコールとのモル比率により変わるため、会合体が水相に分散することにより形成されるゲル状態も変
化する。成分(a)水素添加リン脂質と成分(b)高級アルコールが、水中で会合体を形成し、この会合体が水相に均一に分散することにより均一なゲルを形成するためには、少なくとも1:1〜1:12程度が望ましく、より良好な配合比はモル比で1:1〜1:5であり、さらに好ましくは1:2〜1:5であり、特に好ましくは1:2〜1:3である。
In the gel cosmetic of the present invention, the formation of the aggregates of component (a) hydrogenated phospholipid, component (b) higher alcohol and component (c) water depends on the molar ratio of hydrogenated phospholipid and higher alcohol. Since it changes, the gel state formed when the aggregate is dispersed in the aqueous phase also changes. In order for the component (a) hydrogenated phospholipid and the component (b) higher alcohol to form an aggregate in water, and to form a uniform gel by uniformly dispersing the aggregate in the aqueous phase, at least 1 Is preferably about 1: 1 to 1:12, and a better blending ratio is 1: 1 to 1: 5 in terms of molar ratio, more preferably 1: 2 to 1: 5, and particularly preferably 1: 2 to 1. : 3.
上記望ましいモル比は、ゲル状化粧料の昇温過程におけるDSC曲線の吸熱ピークの頂点を相転移温度として分析するとともに、ゲル状化粧料の結晶性凝集物の有無を観察することにより得られる。 The desirable molar ratio can be obtained by analyzing the apex of the endothermic peak of the DSC curve in the temperature rising process of the gel cosmetic as a phase transition temperature and observing the presence or absence of the crystalline aggregate of the gel cosmetic.
すなわち、成分(a)水素添加リン脂質のみの場合に観察される吸熱ピークに対し、成分(b)高級アルコールのモル比が増えるに従い、徐々に会合体の吸熱ピークが現れる。成分(b)高級アルコールのモル比がさらに増えると、より高温側に吸熱ピークがシフトし、吸熱ピークも徐々にシャープになり始める。さらに成分(b)高級アルコールのモル比が増えると単一ピークが観察され始め、より高温側にシフトし、ピークも徐々に大きくなる。そして、特定のモル比付近で最大の単一ピークとなり、また、その近傍で、最もシャープな単一ピークとなる。 That is, the endothermic peak of the aggregate gradually appears as the molar ratio of component (b) higher alcohol increases with respect to the endothermic peak observed in the case of only component (a) hydrogenated phospholipid. When the molar ratio of the component (b) higher alcohol further increases, the endothermic peak shifts to a higher temperature side, and the endothermic peak begins to become gradually sharper. Furthermore, when the molar ratio of the component (b) higher alcohol increases, a single peak starts to be observed, shifts to a higher temperature side, and the peak gradually increases. And it becomes the maximum single peak in the vicinity of a specific molar ratio, and becomes the sharpest single peak in the vicinity.
さらにこれより成分(b)高級アルコールのモル比が増えると、会合体のピークに加え、成分(b)高級アルコール単独の相転移ピークが徐々に観察される。 Further, when the molar ratio of the component (b) higher alcohol is further increased, the phase transition peak of the component (b) higher alcohol alone is gradually observed in addition to the peak of the aggregate.
上記吸熱ピークにおいて、上記会合体は、モル比が成分(a):成分(b)=3:2付近から徐々に形成され始め、成分(a):成分(b)=1:2〜1:3付近で最大となる。 In the endothermic peak, the aggregate starts to gradually form a molar ratio around component (a): component (b) = 3: 2, and component (a): component (b) = 1: 2 to 1: It becomes the maximum around 3.
また、成分(b)高級アルコールのモル比の増加に伴い、粘度が上昇し、モル比が約1:2〜1:5では外観上において良好なゲルが観察される。モル比が1:5より上になると、白色ゲル状となり、しっとり感も低減し、結晶性の凝集物が観察されるようになる。DSC測定からも、モル比が1:5より上になると成分(b)高級アルコールの水和結晶ピークが観察される事から、この凝集体は成分(b)高級アルコール単独の水和結晶であると確認される。さらに、モル比が約1:2〜1:3においては、全く結晶性の凝集物が観察されず、均一にゲルが形成される。 Further, as the molar ratio of the component (b) higher alcohol increases, the viscosity increases. When the molar ratio is about 1: 2 to 1: 5, a good gel is observed in appearance. When the molar ratio is above 1: 5, a white gel is formed, the moist feeling is reduced, and crystalline aggregates are observed. The DSC measurement also shows that a hydrated crystal peak of component (b) higher alcohol is observed when the molar ratio is above 1: 5, so this aggregate is a hydrated crystal of component (b) higher alcohol alone. It is confirmed. Furthermore, when the molar ratio is about 1: 2 to 1: 3, no crystalline aggregate is observed, and a gel is uniformly formed.
また、会合体の相転移温度は、成分(a)水素添加リン脂質単独の相転移温度及び成分(b)高級アルコール単独の相転移温度よりも高温側に存在し、この会合体はこの相転移温度以下での変化が少なくなるため、これらを単独で配合した場合に比べ高温安定性に優れたゲル状化粧料を得ることができる。 In addition, the phase transition temperature of the aggregate is higher than the phase transition temperature of component (a) hydrogenated phospholipid alone and the phase transition temperature of component (b) higher alcohol alone. Since the change below the temperature is reduced, a gel cosmetic excellent in high temperature stability can be obtained as compared with the case where these are blended alone.
本発明のゲル状化粧料は、更に成分(a)水素添加リン脂質と成分(b)高級アルコールの総量が1〜15%であることが好ましく、より好ましくは、1〜6%である。これ以下であると、粘性に乏しく、逆にこれ以上であると感触的に重くなり柔らかな皮膜感が得られない傾向にある。 In the gel cosmetic of the present invention, the total amount of component (a) hydrogenated phospholipid and component (b) higher alcohol is preferably 1 to 15%, more preferably 1 to 6%. If it is less than this, the viscosity will be poor, and if it is more than this, it will tend to be heavier to the touch and tend not to give a soft film feeling.
本発明のゲル状化粧料は、上記成分(a)水素添加リン脂質、成分(b)高級アルコール、及び成分(c)水に加え、成分(d)として多価アルコールを含有することが好ましい。 The gel cosmetic of the present invention preferably contains a polyhydric alcohol as component (d) in addition to the component (a) hydrogenated phospholipid, component (b) higher alcohol, and component (c) water.
上記成分(d)多価アルコールは、成分(a)水素添加リン脂質と成分(b)高級アルコールを均一に溶解させるために用い、成分(a)水素添加リン脂質と成分(b)高級アルコールを成分(d)多価アルコールに溶解後、成分(c)水を添加し、ゲルを形成させ
ることが好ましい。
The component (d) polyhydric alcohol is used to uniformly dissolve the component (a) hydrogenated phospholipid and the component (b) higher alcohol, and the component (a) hydrogenated phospholipid and component (b) higher alcohol are used. It is preferable to add a component (c) water after melt | dissolving in a component (d) polyhydric alcohol, and to form a gel.
本発明で用いられる成分(d)多価アルコールとしては、ジプロピレングリコール、1,3−ブチレングリコール、グリセリン、ポリエチレングリコール、ソルビトール等が挙げられるが、化粧料製造時の分散性及び使用感の観点からジプロピレングリコール、1,3−ブチレングリコールがより好ましく、ジプロピレングリコールが特に好ましい。 Examples of the component (d) polyhydric alcohol used in the present invention include dipropylene glycol, 1,3-butylene glycol, glycerin, polyethylene glycol, sorbitol and the like, but from the viewpoint of dispersibility and usability during cosmetic production. To dipropylene glycol and 1,3-butylene glycol are more preferable, and dipropylene glycol is particularly preferable.
上記成分(d)多価アルコールは、1種単独又は2種以上を組み合わせて化粧料に配合することができ、その配合量は、特に限定されないが、化粧料製造時の分散性及び使用感の観点から、化粧料の総量を基準として、0.1〜30質量%が好ましく、特に好ましくは1〜20質量%である。 The component (d) polyhydric alcohol can be blended in cosmetics alone or in combination of two or more, and the blending amount is not particularly limited, but the dispersibility and feeling of use during cosmetic production From a viewpoint, 0.1-30 mass% is preferable on the basis of the total amount of cosmetics, Most preferably, it is 1-20 mass%.
本発明のゲル状化粧料の粘度は、使用感の観点から25℃において1000〜20000cpsであることが好ましい。 The viscosity of the gel cosmetic of the present invention is preferably 1000 to 20000 cps at 25 ° C. from the viewpoint of use feeling.
本発明のゲル状化粧料のpHは、ゲルの会合体の高温での長期安定性の観点から5.0以上であることが好ましく、リン脂質の安定性の面から8.0以下であることが好ましい。さらに、好ましくはpH6.0〜7.0である。これは、pHが小さくなると、高温に長期保存することにより、会合体のピークが低温側にシフトし、安定性が低下する傾向があり、逆に、pHが大きくなるとリン脂質自体の安定性が低下する傾向にあるためである。 The pH of the gel cosmetic of the present invention is preferably 5.0 or more from the viewpoint of long-term stability of the gel aggregate at a high temperature, and is 8.0 or less from the viewpoint of phospholipid stability. Is preferred. Further, the pH is preferably 6.0 to 7.0. This is because when the pH decreases, the peak of the aggregate tends to shift to the low temperature side by long-term storage at a high temperature, and the stability tends to decrease. Conversely, when the pH increases, the stability of the phospholipid itself tends to decrease. This is because it tends to decrease.
本発明のゲル状化粧料は、成分(a)水素添加リン脂質、成分(b)高級アルコール、成分(c)水、及び成分(d)多価アルコールに加え、成分(e)としてカルボキシビニルポリマー及びアルキル変性カルボキシビニルポリマーのうち少なくとも一方又は両方を含有することが好ましい。これらを配合することにより、pHの安定性が向上する傾向にある。 In addition to component (a) hydrogenated phospholipid, component (b) higher alcohol, component (c) water, and component (d) polyhydric alcohol, the gel cosmetic of the present invention comprises carboxyvinyl polymer as component (e) And at least one or both of alkyl-modified carboxyvinyl polymer. By blending these, the stability of pH tends to be improved.
本発明のゲル状化粧料の油含有量は、3%未満であることが望ましく、さらに好ましくは、1%未満である。油の含有量が多くなるとゲル構造を壊してしまい、粘度が低下し、安定性が悪くなる。 The oil content of the gel cosmetic of the present invention is desirably less than 3%, more preferably less than 1%. When the oil content increases, the gel structure is broken, the viscosity is lowered, and the stability is deteriorated.
本発明のゲル状化粧料は、化粧品の外観上、半透明状であることが望ましい。 It is desirable that the gel cosmetic of the present invention is translucent in terms of cosmetic appearance.
本発明のゲル状化粧料には、上記の各成分以外に、通常化粧料に用いられる油剤、粉体(顔料、色素、樹脂)、界面活性剤、粘剤、樹脂、防腐剤、香料、紫外線吸収剤(有機系、無機系を含む。UV−A、Bのいずれに対応していても構わない)、溶媒、天然系の植物抽出成分、海藻抽出成分、生薬成分、保湿剤、塩類、酸化防止剤、中和剤、pH調整剤、昆虫忌避剤等の成分を適宜配合することができる。 In addition to the above components, the gel cosmetic of the present invention includes oils, powders (pigments, dyes, resins), surfactants, stickers, resins, preservatives, fragrances, and ultraviolet rays that are commonly used in cosmetics. Absorbent (including organic and inorganic systems, which may be UV-A or B), solvent, natural plant extract component, seaweed extract component, herbal medicine component, moisturizer, salt, oxidation Components such as an inhibitor, a neutralizer, a pH adjuster, and an insect repellent can be appropriately blended.
油剤としては、通常化粧料に用いられる揮発性及び不揮発性の油剤、溶剤、並びに樹脂等が挙げられ、常温で液体、ペースト、固体のいずれであっても構わない。油剤の例としては、例えばイソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸ミリスチル、ラウリン酸ヘキシル、オレイン酸デシル、ミリスチン酸イソプロピル、ジメチルオクタン酸ヘキシルデシル、モノステアリン酸グリセリン、トリオクタン酸グリセリル、トリ−2−ヘプチルウンデカン酸グリセリル、フタル酸ジエチル、モノステアリン酸エチレングリコール、オキシステアリン酸オクチル、リンゴ酸ジイソステアリル等のエステル類、流動パラフィン、パラフィン、ワセリン、スクワラン等の炭化水素、ラノリン、還元ラノリン、液状ラノリン、カルナバロウ、キャンデリラロウ、セレシン、オゾケライト、マイクロクリスタリンワックス等のロウ、ミンク油、ヤシ油、ツバキ油、ゴマ油、ヒマシ
油、オリーブ油等の油脂、ポリエチレンワックス、エチレン・α−オレフィン・コオリゴマー、エチレンプロピレンポリマー等が挙げられる。
Examples of the oil agent include volatile and non-volatile oil agents usually used in cosmetics, solvents, resins, and the like, and may be liquid, paste, or solid at room temperature. Examples of oils include, for example, isononyl isononanoate, isotridecyl isononanoate, myristyl myristate, hexyl laurate, decyl oleate, isopropyl myristate, hexyl decyl dimethyloctanoate, glyceryl monostearate, glyceryl trioctanoate, tri-2- Esters such as glyceryl heptyl undecanoate, diethyl phthalate, ethylene glycol monostearate, octyl oxystearate, diisostearyl malate, hydrocarbons such as liquid paraffin, paraffin, petrolatum, squalane, lanolin, reduced lanolin, liquid lanolin , Carnauba wax, candelilla wax, ceresin, ozokerite, microcrystalline wax, etc., mink oil, palm oil, camellia oil, sesame oil, castor oil, olive oil Fats, polyethylene wax, ethylene-alpha-olefin co-oligomer, ethylene propylene polymers, and the like.
粉体の例としては、赤色104号、赤色102号、赤色226号、赤色201号、赤色202号、黄色4号、黒色401号等の色素、青色1号アルミニウムレーキ、黄色4号アルミニウムレーキ、黄色5号アルミニウムレーキ、黄色203号バリウムレーキ等のレーキ色素、ナイロンパウダー、シルクパウダー、ウレタンパウダー、テフロン(登録商標)パウダー、シリコーンパウダー、ポリメタクリル酸メチルパウダー、セルロースパウダー、シリコーンエラストマー球状粉体、ポリエチレン末等の高分子、黄酸化鉄、ベンガラ、黒酸化鉄、酸化クロム、カーボンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化チタン、酸化セリウム等の白色顔料、タルク、マイカ、セリサイト、カオリン、板状硫酸バリウム等の体質顔料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カルシウム、炭酸マグネシウム、珪酸アルミニウム、珪酸マグネシウム等の金属塩、シリカ、アルミナ等の無機粉体、ベントナイト、スメクタイト、窒化ホウ素、微粒子酸化チタン、微粒子酸化亜鉛等が挙げられ、またこれらを従来公知の表面処理、例えば、N−アシル化リジン処理、アミノ酸処理、親水性高分子処理、油剤処理、シリコーン処理、金属石鹸処理、無機化合物処理、プラズマ処理、メカノケミカル処理等を施したものを使用することも可能である。これらの粉体の形状(球状、棒状、針状、板状、不定形状、燐片状、紡錘状等)に特に制限はない。粉体の大きさとしては、5nm〜100μmの範囲に入るものが好ましく、さらに好ましくは10nm〜25μmである。これらの粉体は単独で処理しても、混合物を形成し、それをまとめて処理しても構わない。また、混合物の色を肌色等に調整したものを処理することも可能である。さらに、微粒子酸化チタン、微粒子酸化亜鉛等の紫外線散乱成分を使用することで紫外線防御機能を有する処理粉体とすることも可能である。 Examples of powders include red No. 104, red No. 102, red No. 226, red No. 201, red No. 202, yellow No. 4, black No. 401, etc., blue No. 1 aluminum lake, yellow No. 4 aluminum lake, Rake dyes such as yellow No. 5 aluminum lake, yellow No. 203 barium lake, nylon powder, silk powder, urethane powder, Teflon (registered trademark) powder, silicone powder, polymethyl methacrylate powder, cellulose powder, silicone elastomer spherical powder, Polymers such as polyethylene powder, yellow iron oxide, bengara, black iron oxide, chromium oxide, carbon black, colored pigments such as ultramarine and bitumen, white pigments such as zinc oxide, titanium oxide and cerium oxide, talc, mica and sericite , Kaolin, extender pigments such as plate-like barium sulfate, mica tita Pearl pigments such as barium sulfate, calcium carbonate, magnesium carbonate, aluminum silicate, magnesium silicate, inorganic powders such as silica and alumina, bentonite, smectite, boron nitride, fine particle titanium oxide, fine particle zinc oxide, etc. These are also conventionally known surface treatments such as N-acylated lysine treatment, amino acid treatment, hydrophilic polymer treatment, oil treatment, silicone treatment, metal soap treatment, inorganic compound treatment, plasma treatment, mechanochemical treatment, etc. It is also possible to use the one with the mark. There are no particular restrictions on the shape of these powders (spherical, rod-like, needle-like, plate-like, indeterminate, flake-like, spindle-like, etc.). The size of the powder is preferably in the range of 5 nm to 100 μm, more preferably 10 nm to 25 μm. These powders may be processed alone or may form a mixture and be processed together. Moreover, it is also possible to process what adjusted the color of the mixture to skin color etc. Furthermore, it is possible to obtain a treated powder having an ultraviolet protection function by using an ultraviolet scattering component such as fine particle titanium oxide or fine particle zinc oxide.
界面活性剤としては、例えばアニオン性界面活性剤、カチオン性界面活性剤、ノニオン性界面活性剤、両性界面活性剤を用いることができる。より詳しくは脂肪酸石鹸、α−アシルスルホン酸塩、N−アシルアミノ酸塩、アルキルスルホン酸塩、アルキルアリルスルホン酸塩、アルキルナフタレンスルホン酸塩、アルキル硫酸塩、アルキルエーテル硫酸塩、アルキルアミド硫酸塩、アルキルリン酸塩、アルキルアミドリン酸塩、アルキロイルアルキルタウリン塩、スルホコハク酸塩、パーフルオロアルキルリン酸エステル等のアニオン性界面活性剤、塩化アルキルトリメチルアンモニウム、塩化ステアリルトリメチルアンモニウム、臭化ステアリルトリメチルアンモニウム、塩化セトステアリルトリメチルアンモニウム、塩化ジステアリルジメチルアンモニウム、塩化ステアリルジメチルベンジルアンモニウム、臭化ベヘニルトリメチルアンモニウム等のカチオン性界面活性剤、ラウリン酸アルカノールアミド、POE(ポリオキシエチレン、以下同じ)ソルビタン脂肪酸エステル、POEグリセリン脂肪酸エステル、POE脂肪酸エステル、ポリエーテル変性シリコーン等のノニオン性界面活性剤、カルボキシベタイン型、アミドベタイン型、スルホベタイン型、ヒドロキシスルホベタイン型、アミドスルホベタイン型、ホスホベタイン型、アミノカルボン酸塩型、イミダゾリン誘導体型、アミドアミン型等の両性界面活性剤が挙げられる。また、サポニン、糖系界面活性剤等の天然系界面活性剤を用いることもできる。 As the surfactant, for example, an anionic surfactant, a cationic surfactant, a nonionic surfactant, and an amphoteric surfactant can be used. More specifically, fatty acid soap, α-acyl sulfonate, N-acyl amino acid salt, alkyl sulfonate, alkyl allyl sulfonate, alkyl naphthalene sulfonate, alkyl sulfate, alkyl ether sulfate, alkyl amide sulfate, Anionic surfactants such as alkyl phosphates, alkylamide phosphates, alkyloyl alkyl taurates, sulfosuccinates, perfluoroalkyl phosphates, alkyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide , Cationic surfactants such as cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylbenzylammonium chloride, behenyltrimethylammonium bromide, Nonionic surfactants such as acid alkanolamide, POE (polyoxyethylene, the same shall apply hereinafter) sorbitan fatty acid ester, POE glycerin fatty acid ester, POE fatty acid ester, polyether-modified silicone, carboxybetaine type, amide betaine type, sulfobetaine type And amphoteric surfactants such as hydroxysulfobetaine type, amide sulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type, and amidoamine type. Natural surfactants such as saponins and sugar surfactants can also be used.
粘剤、樹脂の例としては、ポリアクリル酸ナトリウム、セルロースエーテル、アルギン酸カルシウム、カルボキシビニルポリマー、エチレン/アクリル酸共重合体、ビニルピロリドン系ポリマー、ビニルアルコール/ビニルピロリドン共重合体、窒素置換アクリルアミド系ポリマー、カチオン化ガーガム等のカチオン系ポリマー、ジメチルアクリルアンモニウム系ポリマー、POE/POP(ポリオキシプロピレン、以下同じ)共重合体、ポリビニルアルコール、プルラン、デオキシリボ核酸及びその塩、コンドロイチン硫酸等の酸性ムコ多糖類及びその塩、タマリンド種子多糖類、寒天、キサンタンガム、カラギーナン、ハイメトキシルペクチン、ローメトキシルペクチン、ガーガム、アラビアゴム、結晶セ
ルロース、アラビノガラクタン、カラヤガム、トラガカントガム、アルギン酸、ヒアルロン酸及びその塩、アルブミン、カゼイン、カードラン、ジェランガム、デキストラン、セルロース、ポリエチレンイミン、高重合ポリエチレングリコール、合成ラテックス等が挙げられる。
Examples of adhesives and resins include sodium polyacrylate, cellulose ether, calcium alginate, carboxyvinyl polymer, ethylene / acrylic acid copolymer, vinyl pyrrolidone polymer, vinyl alcohol / vinyl pyrrolidone copolymer, nitrogen substituted acrylamide type Polymers, cationic polymers such as cationized gar gum, dimethylacrylammonium polymers, POE / POP (polyoxypropylene, hereinafter the same) copolymer, polyvinyl alcohol, pullulan, deoxyribonucleic acid and its salts, chondroitin sulfate, etc. Sugars and salts thereof, tamarind seed polysaccharide, agar, xanthan gum, carrageenan, high methoxyl pectin, low methoxyl pectin, gar gum, gum arabic, crystalline cellulose, arabinogalactan Karaya, gum tragacanth, alginic acid, hyaluronic acid and salts thereof, albumin, casein, curdlan, gellan gum, dextran, cellulose, polyethyleneimine, highly polymerized polyethylene glycol, synthetic latex, and the like.
防腐剤としては、例えば安息香酸、安息香酸ナトリウム、ウンデシレン酸、サリチル酸、ソルビン酸又はその塩、デヒドロ酢酸又はその塩、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸ブチル、パラオキシ安息香酸イソブチル、パラオキシ安息香酸ベンジル等の有機酸及びその誘導体、イソプロピルメチルフェノール、グルコン酸クロルヘキシジン、クレゾール、チモール、パラクロロフェノール、フェニルエチルアルコール、フェニルフェノール、フェニルフェノールナトリウム、フェノキシエタノール、フェノキシジグリコール、フェノール、ベンジルアルコール等のフェノール類、塩化ステアリルトリメチルアンモニウム、塩化セチルトリメチルアンモニウム、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化メチルベンゼトニウム、塩化ラウリルトリメチルアンモニウム、臭化アルキルイソキノリウム、臭化ドミフェノン等の4級アンモニウム塩、茶エキス、ヒノキチオール、リンゴエキス等の植物抽出液、また、クロラミンT、クロルヘキシジン、ジンクピリチオン等を挙げることができる。 Examples of the preservative include benzoic acid, sodium benzoate, undecylenic acid, salicylic acid, sorbic acid or a salt thereof, dehydroacetic acid or a salt thereof, methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, isopropyl paraoxybenzoate, Organic acids such as butyl paraoxybenzoate, isobutyl paraoxybenzoate, benzyl paraoxybenzoate and their derivatives, isopropylmethylphenol, chlorhexidine gluconate, cresol, thymol, parachlorophenol, phenylethyl alcohol, phenylphenol, sodium phenylphenol, phenoxyethanol , Phenols such as phenoxydiglycol, phenol, benzyl alcohol, stearyltrimethylammonium chloride, cetyl chloride Quaternary ammonium salts such as limethylammonium, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, methylbenzethonium chloride, lauryltrimethylammonium chloride, alkylisoquinolium bromide, domifenone bromide, tea extract, hinokitiol, apple extract, etc. And chloramine T, chlorhexidine, zinc pyrithione and the like.
有機系紫外線吸収剤の例としては、パラメトキシケイ皮酸2−エチルヘキシル、パラジメチルアミノ安息香酸2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸、2,2’−ジヒドロキシ−4−メトキシベンゾフェノン、p−メトキシハイドロケイ皮酸 ジエタノールアミン塩、パラアミノ安息香酸(以後、PABAと略す)、サリチル酸ホモメンチル、メチル−O−アミノベンゾエート、2−エチルヘキシル−2−シアノ−3,3−ジフェニルアクリレート、オクチルジメチルPABA、サリチル酸オクチル、2−フェニル−ベンズイミダゾール−5−硫酸、サリチル酸トリエタノールアミン、3−(4−メチルベンジリデン)カンフル、2,4−ジヒドロキシベンゾフェニン、2,2’,4,4’−テトラヒドロキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2−ヒドロキシ−4−N−オクトキシベンゾフェノン、4−イソプロピルジベンゾイルメタン、ブチルメトキシジベンゾイルメタン、4−(3,4−ジメトキシフェニルメチレン)−2,5−ジオキソ−1−イミダゾリジンプロピオン酸2−エチルヘキシル等が挙げられる。 Examples of organic ultraviolet absorbers include 2-methoxyhexyl paramethoxycinnamate, 2-ethylhexyl paradimethylaminobenzoate, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfate, 2,2′-dihydroxy-4-methoxybenzophenone, p-methoxyhydrocinnamic acid diethanolamine salt, paraaminobenzoic acid (hereinafter abbreviated as PABA), homomenthyl salicylate, methyl-O-aminobenzoate, 2-ethylhexyl-2-cyano -3,3-diphenyl acrylate, octyldimethyl PABA, octyl salicylate, 2-phenyl-benzimidazole-5-sulfuric acid, triethanolamine salicylate, 3- (4-methylbenzylidene) camphor, 2,4-dihydroxy Nzophenine, 2,2 ′, 4,4′-tetrahydroxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone, 2-hydroxy-4-N-octoxybenzophenone, 4-isopropyldibenzoylmethane, Examples include butylmethoxydibenzoylmethane, 4- (3,4-dimethoxyphenylmethylene) -2,5-dioxo-1-imidazolidinepropionate 2-ethylhexyl, and the like.
溶媒の例としては、精製水、環状シリコーン、エタノール、軽質流動イソパラフィン、低級アルコール、エーテル類、LPG、フルオロカーボン、N−メチルピロリドン、フルオロアルコール、次世代フロン等が挙げられる。 Examples of the solvent include purified water, cyclic silicone, ethanol, light liquid isoparaffin, lower alcohol, ethers, LPG, fluorocarbon, N-methylpyrrolidone, fluoroalcohol, and next-generation chlorofluorocarbon.
天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、アシタバエキス、アボガドエキス、アマチャエキス、アルテアエキス、アルニカエキス、アロエエキス、アンズエキス、アンズ核エキス、イチョウエキス、ウイキョウエキス、ウコンエキス、ウーロン茶エキス、エイジツエキス、エチナシ葉エキス、オウゴンエキス、オウバクエキス、オウレンエキス、オオムギエキス、オトギリソウエキス、オドリコソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解エラスチン、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カルカデエキス、カキョクエキス、キウイエキス、キナエキス、キューカンバーエキス、グアノシン、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クレマティスエキス、クロレラエキス、クワエキス、ゲンチアナエキス、紅茶エキス、酵母エキス、ゴボウエキス、コメヌカ発酵エキス、コメ胚芽油、コンフリーエキス、コラーゲン、コケモモエキス、サイシンエキス、サイコエキス、サイ
タイ抽出液、サルビアエキス、サボンソウエキス、ササエキス、サンザシエキス、サンショウエキス、シイタケエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シモツケソウエキス、シャクヤクエキス、ショウブ根エキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、ゼニアオイエキス、センキュウエキス、センブリエキス、ダイズエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チガヤエキス、チンピエキス、トウキエキス、トウキンセンカエキス、トウニンエキス、トウヒエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、ハイビスカスエキス、バクモンドウエキス、ハスエキス、パセリエキス、蜂蜜、ハマメリスエキス、パリエタリアエキス、ヒキオコシエキス、ビサボロール、ビワエキス、フキタンポポエキス、フキノトウエキス、ブクリョウエキス、ブッチャーブルームエキス、ブドウエキス、プロポリス、ヘチマエキス、ベニバナエキス、ペパーミントエキス、ボダイジュエキス、ボタンエキス、ホップエキス、マツエキス、マロニエエキス、ミズバショウエキス、ムクロジエキス、メリッサエキス、モモエキス、ヤグルマギクエキス、ユーカリエキス、ユキノシタエキス、ユズエキス、ヨクイニンエキス、ヨモギエキス、ラベンダーエキス、リンゴエキス、レタスエキス、レモンエキス、レンゲソウエキス、ローズエキス、ローズマリーエキス、ローマカミツレエキス、ローヤルゼリーエキス等を挙げることができる。
Examples of natural plant extract ingredients, seaweed extract ingredients, and herbal medicine ingredients are Ashitaba extract, Avocado extract, Achacha extract, Altea extract, Arnica extract, Aloe extract, Apricot extract, Apricot extract, Ginkgo biloba extract, fennel extract, Turmeric Extract, Oolong tea extract, Ages extract, Echinacea leaf extract, Ogon extract, Oat extract, Auren extract, Barley extract, Hypericum extract, Oyster extract, Dutch mustard extract, Orange extract, Seawater dried product, Seaweed extract, Hydrolyzed elastin, Hydrolysis Wheat powder, hydrolyzed silk, chamomile extract, carrot extract, cormorant extract, licorice extract, calcade extract, oyster extract, kiwi extract, kina extract, cucumber extract, guanosine, gardenia Kiss, Kumazasa extract, Clara extract, Walnut extract, Grapefruit extract, Clematis extract, Chlorella extract, Mulberry extract, Gentian extract, Tea extract, Yeast extract, Burdock extract, Rice bran extract, Rice germ oil, Comfrey extract, Collagen, Cowberry extract Extract Extract, Horsetail extract, Horseshoe extract, Hawthorn extract, Elderberry extract, Yarrow extract, Japanese peppermint extract, Sauce Extract, mallow extract, senkyu extract, assembly extract, soybean extract, lysium extract, thyme extract, tea extract, clove extract, chigaya extract, chimpi extract, touki extract, tofu extract, tonin extract, spruce extract, dokudami extract, tomato extract, natto extract, Carrot extract, garlic extract, wild rose extract, hibiscus extract, bacmond extract, lotus extract, parsley extract, honey, hamamelis extract, parietaria extract, toad extract, bisabolol, loquat extract, dandelion extract, burdock extract, butterfly extract, butcher bloom extract, Grape extract, propolis, loofah extract, safflower extract, peppermint extract, bodaiju extract, button extract, hop exhaust Pine extract Examples include rose extract, rosemary extract, Roman chamomile extract, royal jelly extract and the like.
本発明のゲル状化粧料は、通常の方法によって製造することができ、ローション、乳液、クリーム、エッセンス、ジェル、パック等の基礎化粧料、ファンデーション、口紅等のメイクアップ化粧料、シャンプー、リンス、ヘアトリートメント、ヘアクリーム、ヘアトニック、ヘアリクイド、セットジェル、ヘアムース、セットローション、ヘアスプレー、育毛剤等の毛髪化粧料、及び入浴剤等として適用することができる。 The gel cosmetic of the present invention can be produced by a usual method, such as basic cosmetics such as lotion, emulsion, cream, essence, gel and pack, makeup cosmetics such as foundation and lipstick, shampoo, rinse, It can be applied as hair treatments, hair creams, hair tonics, hair liquids, set gels, hair mousses, set lotions, hair sprays, hair cosmetics such as hair restorers, and bathing agents.
以下、実施例を挙げて本発明を更に詳細に説明するが、本発明はこれに限定されるものではない。尚、配合量は全て質量%である。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated still in detail, this invention is not limited to this. In addition, all compounding quantities are the mass%.
(実施例1〜3、比較例1〜2)
本発明のゲル状化粧料における成分(a)水素添加リン脂質、及び成分(b)高級アルコールとして、水素添加大豆リン脂質A〜Eとセチルアルコールを用いた例を表1に示す。また、各実施例のゲル形成、及び均一分散性の評価結果も併せて記す。
(Examples 1-3, Comparative Examples 1-2)
Table 1 shows examples in which hydrogenated soybean phospholipids A to E and cetyl alcohol are used as the component (a) hydrogenated phospholipid and the component (b) higher alcohol in the gel cosmetic of the present invention. Moreover, the gel formation of each Example and the evaluation result of uniform dispersibility are also described collectively.
(調整方法)
成分(1)〜(5)のいずれかの水素添加大豆リン脂質A〜Eと(6)セチルアルコール、及び(7)ジプロピレングリコールを80℃にて混合溶解し、80℃の(8)精製水を投入、攪拌後、冷却し、実施例1〜3、比較例1〜2の化粧料を得た。
(Adjustment method)
Hydrogenated soybean phospholipids A to E of any of the components (1) to (5), (6) cetyl alcohol, and (7) dipropylene glycol are mixed and dissolved at 80 ° C., and (8) purification at 80 ° C. Water was added, stirred and then cooled to obtain cosmetics of Examples 1 to 3 and Comparative Examples 1 and 2.
<ゲル形成性評価>
実施例及び比較例の化粧料を、目視により判定、以下の評価基準により評価した。
◎:粘性あり
○:やや粘性あり
×:粘性なし
<Evaluation of gel formation>
The cosmetics of Examples and Comparative Examples were visually judged and evaluated according to the following evaluation criteria.
◎: Viscosity ○: Slightly viscous ×: No viscosity
<均一分散性評価>
実施例及び比較例の化粧料を、目視により判定、以下の評価基準により評価した。
◎:分離なし、均一
○:分離なし、やや均一
×:分離、不均一
<Uniform dispersibility evaluation>
The cosmetics of Examples and Comparative Examples were visually judged and evaluated according to the following evaluation criteria.
◎: No separation, uniform ○: No separation, somewhat uniform ×: Separation, non-uniformity
表1から明らかなように、PC含有量が50質量%未満の比較例2では、均一な分散状態にはなるものの、高級アルコールとの会合体形成において増粘機構に乏しく十分なゲル構造は得られず、ゲル状の化粧料は得られなかった。 As can be seen from Table 1, Comparative Example 2 having a PC content of less than 50% by mass has a uniform dispersion state, but has a poor gel thickening mechanism in forming an association with a higher alcohol, and a sufficient gel structure is obtained. No gel-like cosmetic was obtained.
さらに、成分(a)水素添加リン脂質における酸性リン脂質の割合が、PC含有量に対して10質量%未満である比較例1の場合、高級アルコールとの会合体を水相に均一に分散することができず、凝集を起こし、均一なゲルは形成されなかった。 Further, in the case of Comparative Example 1 in which the proportion of the acidic phospholipid in the component (a) hydrogenated phospholipid is less than 10% by mass with respect to the PC content, the aggregate with the higher alcohol is uniformly dispersed in the aqueous phase. Could not be agglomerated and a uniform gel was not formed.
さらに、実施例1及び2から分かるように、成分(a)水素添加リン脂質における酸性リン脂質のPC含有量に対する質量比が、10〜30質量%であると、ゲル形成性が特に良好であった。 Furthermore, as can be seen from Examples 1 and 2, when the mass ratio of the component (a) hydrogenated phospholipid to the PC content of acidic phospholipid is 10 to 30% by mass, the gel-forming property was particularly good. It was.
次に、成分(a)としての水素添加大豆リン脂質、成分(b)としてのセチルアルコール及び成分(c)としての水とによる会合体の形成を示差走査熱量計(以下DSC)測定によって、観察した。なお、水素添加大豆リン脂質として、PC含有量75%、酸性リン脂質10%(PCに対する酸性リン脂質の割合は13.3%)の水素添加大豆リン脂質Fを使用した。 Next, the formation of aggregates with hydrogenated soybean phospholipid as component (a), cetyl alcohol as component (b) and water as component (c) was observed by differential scanning calorimetry (hereinafter DSC) measurement. did. As hydrogenated soybean phospholipid, hydrogenated soybean phospholipid F having a PC content of 75% and acidic phospholipid of 10% (the ratio of acidic phospholipid to PC was 13.3%) was used.
図1に、水素添加大豆リン脂質Fとセチルアルコールとジプロピレングリコール、水からなる系において、水素添加大豆リン脂質Fとセチルアルコールのモル比を変化させて調製した化粧料(比較例3〜5、参考例4〜5、実施例6,及び実施例8)のDSC測定結果を示す。また、その組成を実施例7,実施例9〜13,及び比較例6とともに表2に示す。あわせて、比較例3〜6、参考例4〜5、及び実施例6〜13の化粧料の性状、粘度、偏光顕微鏡観察結果も表2に示す。 FIG. 1 shows cosmetics prepared by changing the molar ratio of hydrogenated soybean phospholipid F and cetyl alcohol in a system consisting of hydrogenated soybean phospholipid F, cetyl alcohol, dipropylene glycol and water (Comparative Examples 3 to 5). DSC measurement results of Reference Examples 4 to 5, Example 6 and Example 8) are shown. The composition is shown in Table 2 together with Example 7, Examples 9 to 13, and Comparative Example 6. In addition, Table 2 also shows properties, viscosities, and polarizing microscope observation results of the cosmetics of Comparative Examples 3 to 6, Reference Examples 4 to 5, and Examples 6 to 13.
比較例3〜6、参考例4〜5、及び実施例6〜13の化粧料は、水素添加大豆リン脂質Fとセチルアルコール及びジプロピレングリコールを80℃にて混合溶解し、80℃の精製水を投入、攪拌後、冷却して得たものである。 The cosmetics of Comparative Examples 3 to 6, Reference Examples 4 to 5, and Examples 6 to 13 were prepared by mixing and dissolving hydrogenated soybean phospholipid F, cetyl alcohol, and dipropylene glycol at 80 ° C., and purified water at 80 ° C. Was added, stirred and then cooled.
また、本実施例におけるDSC測定には、具体的にDSC6220(SIIナノテクノロジー(株)社製)を用いて行い、昇温過程におけるDSC曲線の吸熱ピークの頂点を相転移温度とした。 Further, DSC measurement in this example was performed specifically using DSC 6220 (manufactured by SII Nanotechnology Co., Ltd.), and the peak of the endothermic peak of the DSC curve in the temperature rising process was defined as the phase transition temperature.
図1において、成分(a)である水素添加大豆リン脂質Fのみの場合(比較例3)には、約52℃、57℃にピークが観察されるが、成分(b)であるセチルアルコールのモル比が増えるに従い、徐々に会合体のピークが現れる。モル比が成分(a):成分(b)=1:1付近(参考例4)からより高温側にピークがシフトし、ピークも徐々にシャープになり始める。さらにモル比が成分(a):成分(b)=1:1.6付近(参考例5)から単一ピークが観察され始め、より高温側にシフトし、ピークも徐々に大きくなる。さらには、モル比が成分(a):成分(b)=1:2〜1:3付近(実施例6〜実施例8)で最大の単一ピークとなる。また、モル比が成分(a):成分(b)=1:2の時が最もシャープな単一ピークとなる。 In FIG. 1, in the case of only the hydrogenated soybean phospholipid F as the component (a) (Comparative Example 3), peaks are observed at about 52 ° C. and 57 ° C., but the cetyl alcohol as the component (b) As the molar ratio increases, aggregate peaks gradually appear. The peak shifts to a higher temperature from the molar ratio of component (a): component (b) = 1: 1 ( Reference Example 4), and the peak gradually begins to become sharper. Furthermore, a single peak starts to be observed when the molar ratio is around component (a): component (b) = 1: 1.6 ( Reference Example 5), shifts to a higher temperature side, and the peak gradually increases. Furthermore, the maximum single peak is obtained when the molar ratio is around component (a): component (b) = 1: 2 to 1: 3 (Examples 6 to 8). When the molar ratio is component (a): component (b) = 1: 2, the sharpest single peak is obtained.
さらにこれより成分(b)のモル比が増えると、会合体のピークに加え、セチルアルコール単独の相転移ピークが徐々に観察される。 Further, when the molar ratio of component (b) is further increased, the phase transition peak of cetyl alcohol alone is gradually observed in addition to the peak of the aggregate.
このことから、この会合体は、モル比が成分(a):成分(b)=3:2付近(比較例5)から徐々に形成され始め、成分(a):成分(b)=1:2〜1:3付近で最大となる事がわかる。さらに、セチルアルコールのモル比を増やしていくと、会合体のピークとは別に、セチルアルコールの吸熱ピークが52℃付近に観察されるようになり、会合体とは別に、単独のセチルアルコールが存在する事がわかる。この会合体のピークが最大で67℃付近にあることから、60℃以下においては安定な会合体が形成されていることがわかる。 From this, this aggregate starts to gradually form from the vicinity of the component (a): component (b) = 3: 2 (Comparative Example 5), and the component (a): component (b) = 1: It turns out that it becomes the maximum around 2-1: 3. Furthermore, when the molar ratio of cetyl alcohol is increased, an endothermic peak of cetyl alcohol is observed around 52 ° C. separately from the peak of the aggregate, and there is a single cetyl alcohol separately from the aggregate. I understand that Since the peak of this aggregate is around 67 ° C. at the maximum, it can be seen that a stable aggregate is formed at 60 ° C. or lower.
表2における、性状、粘度及び偏光顕微鏡観察に関する測定方法を次に示す。 The measurement methods related to properties, viscosity, and observation under a polarizing microscope in Table 2 are shown below.
<性状>
外観を肉眼観察した。
<Properties>
The appearance was visually observed.
<粘度測定方法>
芝浦システム株式会社製、単一円筒型回転粘度計(ローターNo.3、25℃、12rpm及びローターNo.4、25℃、12rpm)にて測定した。
<Viscosity measurement method>
It was measured with a single cylindrical rotational viscometer (rotor No. 3, 25 ° C., 12 rpm and rotor No. 4, 25 ° C., 12 rpm) manufactured by Shibaura System Co., Ltd.
<偏光顕微鏡観察>
株式会社ニコン社製、偏光顕微鏡ECLIPSE E600W POLにて偏光下において観察し、以下の評価基準により評価した。
○:結晶性凝集物なし
△:若干凝集物あり
×:結晶性凝集物あり
<Observation with polarizing microscope>
The product was observed under polarized light with a polarizing microscope ECLIPSE E600W POL manufactured by Nikon Corporation and evaluated according to the following evaluation criteria.
○: No crystalline aggregate Δ: Some aggregate present ×: Crystal aggregate present
表2からわかるように、セチルアルコールの配合量の増加に伴い、粘度が上昇し、モル比が約1:2〜1:5では外観上において良好なゲルが観察された(実施例6〜8、参考例9〜10)。モル比が1:5より上になると、白色ゲル状となり、しっとり感も低減し、偏光顕微鏡観察からは、結晶性の凝集物が観察された(参考例11〜13)。DSC測定からも、モル比が1:5より上になるとセチルアルコールの水和結晶ピークが観察される事から、この凝集体はセチルアルコール単独の水和結晶であると確認される。さらに、モル比が約1:2〜1:3においては、偏光顕微鏡において全く結晶性の凝集物が観察されず、均一にゲルが形成されていることが観察された(実施例6〜8)。 As can be seen from Table 2, with the increase in the amount of cetyl alcohol, the viscosity increased. When the molar ratio was about 1: 2 to 1: 5, a good gel was observed on the appearance (Examples 6 to 8). Reference Examples 9 to 10). When the molar ratio was above 1: 5, a white gel was formed, and the moist feeling was reduced. From observation with a polarizing microscope, crystalline aggregates were observed ( Reference Examples 11 to 13). DSC measurement also shows that a hydrated crystal peak of cetyl alcohol is observed when the molar ratio is above 1: 5, and this aggregate is confirmed to be a hydrated crystal of cetyl alcohol alone. Furthermore, when the molar ratio was about 1: 2 to 1: 3, no crystalline aggregate was observed with a polarizing microscope, and it was observed that a gel was uniformly formed (Examples 6 to 8). .
以上のことから、水素添加大豆リン脂質とセチルアルコールは水中で会合体を形成し、この会合体が水相に均一に分散することにより均一なゲルを形成していると考えられる。本発明において、図1のDSC結果及び表2の結果を総合的に考えると、良好な配合比はモル比で1:1〜1:5であり、さらに好ましくは1:2〜1:5であり、特に好ましくは1:2〜1:3であることがわかる。 From the above, it is considered that the hydrogenated soybean phospholipid and cetyl alcohol form an aggregate in water, and the aggregate is uniformly dispersed in the aqueous phase to form a uniform gel. In the present invention, considering the DSC results in FIG. 1 and the results in Table 2 in general, a good blending ratio is 1: 1 to 1: 5 in molar ratio, more preferably 1: 2 to 1: 5. It can be seen that it is particularly preferably 1: 2 to 1: 3.
また、今回の会合体の相転移温度は約68℃となり、水素添加大豆リン脂質単独の相転移温度(約52℃、57℃)及びセチルアルコール単独の相転移温度(約37℃、約52℃)よりも高温側に存在し、この会合体はこの相転移温度以下での変化が少なくなるため、これらを単独で配合した場合に比べ高温安定性に優れたゲル状化粧料を得ることができる。 In addition, the phase transition temperature of this aggregate is about 68 ° C, the phase transition temperature of hydrogenated soybean phospholipid alone (about 52 ° C, 57 ° C) and the phase transition temperature of cetyl alcohol alone (about 37 ° C, about 52 ° C). ), And the aggregate is less likely to change below this phase transition temperature. Therefore, a gel-like cosmetic having excellent high-temperature stability can be obtained as compared with the case where these are blended alone. .
次に、この水素添加大豆リン脂質とセチルアルコールのモル比を、1:2に固定し、pHを変化させて調製した実施例14〜20のゲル状化粧料を表3に示す。さらに45℃に4ヶ月保存した際のDSC測定における会合体のピーク温度の変化率を合わせて示す。 Next, Table 3 shows gel cosmetics of Examples 14 to 20 prepared by fixing the molar ratio of the hydrogenated soybean phospholipid and cetyl alcohol to 1: 2 and changing the pH. Furthermore, the change rate of the peak temperature of the aggregate in DSC measurement when stored at 45 ° C. for 4 months is also shown.
<pH測定>
堀場製作所製、pHメーター(F−55)にて測定を行った。
<PH measurement>
Measurement was performed with a pH meter (F-55) manufactured by Horiba.
<ピーク温度の変化率評価>
◎:変化率5%以下
○:変化率5〜10%以下
×:変化率10%以上
<Evaluation of change rate of peak temperature>
◎:
表3からわかるように、pHの増加に伴い、ピーク温度のシフトが抑制され、pH5.0以上においては、4ヶ月、45℃に保存した後もピークのシフトは少なく、会合体は変化していない。さらにpH6.0以上においては、ピークのシフトはほとんどなく安定な会合体が保持されていることがわかる。 As can be seen from Table 3, as the pH increases, the peak temperature shift is suppressed. At pH 5.0 or higher, the peak shift is small even after storage at 45 ° C. for 4 months, and the aggregates change. Absent. Furthermore, it can be seen that at pH 6.0 or higher, there is almost no peak shift and a stable aggregate is retained.
(実施例21、23〜25、28、参考例22、26 ゲル状美容液)
表4に示す組成のゲル状美容液を調製し、使用感、保湿感、及び安定性に関して評価を行った。
( Examples 21, 23-25, 28, Reference Examples 22, 26 gel cosmetic liquid)
Gel cosmetic liquids having the compositions shown in Table 4 were prepared and evaluated for feeling of use, moisturizing feeling, and stability.
(調製方法)
1.成分(1)〜(5)を80℃にて、混合、溶解する(a)。
2.成分(6)〜(10)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却後、ジェルを得た。
(Preparation method)
1. Components (1) to (5) are mixed and dissolved at 80 ° C. (a).
2. Components (6) to (10) are mixed and dissolved at 80 ° C. (b).
3. (B) was added to (a) and stirred, and after cooling, a gel was obtained.
<使用感評価方法>
専門評価パネラー20名により、刺激感のなさ、べたつきのなさ、しっとり感、柔らかな皮膜感について5段階評価し、更にその平均点から下記基準により判定した。
<Usage evaluation method>
Twenty professional evaluation panelists evaluated five levels of non-irritating, non-sticky, moist, and soft film feeling, and further judged from the average points according to the following criteria.
5段階評価
5点:非常に良い
4点:良い
3点:普通
2点:やや悪い
1点:悪い
5-
判定
◎:平均点が4.5点以上
○:平均点が3.5点以上4.5点未満
△:平均点が2.5点以上3.5点未満
×:平均点が2.5点未満
Judgment ◎: Average score is 4.5 or more ○: Average score is 3.5 or more and less than 4.5 Δ: Average score is 2.5 or more and less than 3.5 ×: Average score is 2.5 Less than
<安定性試験>
実施例21〜28のゲル状美容液を、0℃、室温、40℃に保存し、1か月後の外観及び粘度変化を測定、以下の評価基準により評価した。
◎:分離なし、10%以上の粘度変化なし
○:分離なし、10〜20%の粘度変化あり
×:分離あり
<Stability test>
The gel cosmetic liquids of Examples 21 to 28 were stored at 0 ° C., room temperature, and 40 ° C., and the appearance and viscosity change after one month were measured and evaluated according to the following evaluation criteria.
◎: No separation, no change in viscosity of 10% or more ○: No separation, change in viscosity of 10-20% ×: Separation
表4に示すとおり、本発明の化粧料は刺激感がなく、べとつかず、しっとり感、柔らかな皮膜感、経日安定性に優れたものであることは明らかである。 As shown in Table 4, it is clear that the cosmetic of the present invention has no irritation, is not sticky, has a moist feeling, a soft film feeling, and excellent stability over time.
(参考例29 ゲル状乳液)
成分名 配合量(質量%)
(1)ステアリン酸 1.0
(2)ステアリン酸グリセリンエステル 1.0
(3)セチルアルコール 1.0
(4)コレステロール 0.5
(5)流動パラフィン 0.2
(6)メチルポリシロキサン 0.4
(7)スクワラン 0.1
(8)ブチルパラベン 微 量
(9)水素添加大豆レシチン(*) 1.0
(10)アシルグルタミン酸塩 0.5
(11)キサンタンガム 0.5
(14)グリセリン 2.0
(15)ジプロピレングリコール 3.0
(16)水酸化カリウム 適 量
(17)エデト酸二ナトリウム 0.01
(18)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加大豆レシチン(*) PC含有量70%、酸性リン脂質14%(対PC20%)
( Reference Example 29 Gelled emulsion)
Ingredient name Compounding amount (mass%)
(1) Stearic acid 1.0
(2) Steric acid glycerin ester 1.0
(3) Cetyl alcohol 1.0
(4) Cholesterol 0.5
(5) Liquid paraffin 0.2
(6) Methyl polysiloxane 0.4
(7) Squalane 0.1
(8) Butylparaben (9) Hydrogenated soybean lecithin (*) 1.0
(10) Acyl glutamate 0.5
(11) Xanthan gum 0.5
(14) Glycerin 2.0
(15) Dipropylene glycol 3.0
(16) Potassium hydroxide appropriate amount (17) Disodium edetate 0.01
(18) Residual amount of purified water -------------------------
Total 100.0
Hydrogenated soybean lecithin (*) PC content 70%, acidic phospholipid 14% (vs PC 20%)
(調製方法)
1.成分(1)〜(9)を80℃にて、混合、溶解する(a)。
2.成分(10)〜(18)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却後、乳液を得た。
(Preparation method)
1. Components (1) to (9) are mixed and dissolved at 80 ° C. (a).
2. Components (10) to (18) are mixed and dissolved at 80 ° C. (b).
3. (B) was added to (a) and stirred, and after cooling, an emulsion was obtained.
(参考例30 ゲル状化粧水)
成分名 配合量(質量%)
(1)エタノール 10.0
(2)POE(60)硬化ヒマシ油 0.5
(3)水素添加大豆レシチン(**) 0.5
(4)ベヘニルアルコール 0.4
(5)グリセリン 3.0
(6)1,3−ブチレングリコール 7.0
(7)ジプロピレングリコール 3.0
(8)ポリエチレングリコール1500 1.0
(9)水酸化ナトリウム 適 量
(10)リン酸塩 微 量
(11)メチルパラベン 微 量
(12)エデト酸四ナトリウム 0.01
(13)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加大豆レシチン(**) PC含有量80%、酸性リン脂質10%(対PC12.5%)
( Reference Example 30 Gel lotion)
Ingredient name Compounding amount (mass%)
(1) Ethanol 10.0
(2) POE (60) hydrogenated castor oil 0.5
(3) Hydrogenated soybean lecithin (**) 0.5
(4) Behenyl alcohol 0.4
(5) Glycerin 3.0
(6) 1,3-butylene glycol 7.0
(7) Dipropylene glycol 3.0
(8) Polyethylene glycol 1500 1.0
(9) Sodium hydroxide appropriate amount (10) Phosphate fine amount (11) Methyl paraben fine amount (12) Tetosodium edetate 0.01
(13) Purified water remaining amount -------------------------
Total 100.0
Hydrogenated soybean lecithin (**) PC content 80%, acidic phospholipid 10% (vs PC 12.5%)
(調製方法)
1.成分(1)〜(8)を50℃にて、混合、溶解する(a)。
2.成分(9)〜(13)を混合、溶解する(b)。
3.(b)に(a)を添加して攪拌し、冷却後、化粧水を得た。
(Preparation method)
1. Components (1) to (8) are mixed and dissolved at 50 ° C. (a).
2. Components (9) to (13) are mixed and dissolved (b).
3. (A) was added to (b) and stirred, and after cooling, a lotion was obtained.
(参考例31 ゲル状クリーム)
成分名 配合量(質量%)
(1)ステアリン酸 1.0
(2)モノイソステアリン酸ソルビタン 1.0
(3)ステアリルアルコール 3.0
(4)ベヘニルアルコール 1.0
(5)オレイルアルコール 0.5
(6)コレステロール 0.5
(7)フィトステロール 0.2
(8)スクワラン 1.0
(9)ミリスチン酸オクチルドデシル 1.0
(10)メチルシクロポリシロキサン 1.0
(11)ブチルパラベン 微 量
(12)水素添加大豆レシチン(***) 4.0
(13)ジプロピレングリコール 20.0
(14)キサンタンガム 0.1
(15)グリセリン 7.0
(16)1,3−ブチレングリコール 5.0
(17)ジイソプロパノールアミン 適 量
(18)エデト酸二カリウム 0.05
(19)フェノキシエタノール 0.02
(20)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加大豆レシチン(***) PC含有量60%、酸性リン脂質20%(対PC約33%)
( Reference Example 31 gel cream)
Ingredient name Compounding amount (mass%)
(1) Stearic acid 1.0
(2) Sorbitan monoisostearate 1.0
(3) Stearyl alcohol 3.0
(4) Behenyl alcohol 1.0
(5) Oleyl alcohol 0.5
(6) Cholesterol 0.5
(7) Phytosterol 0.2
(8) Squalane 1.0
(9) Octyldodecyl myristate 1.0
(10) Methylcyclopolysiloxane 1.0
(11) Butylparaben (12) Hydrogenated soybean lecithin (***) 4.0
(13) Dipropylene glycol 20.0
(14) Xanthan gum 0.1
(15) Glycerin 7.0
(16) 1,3-butylene glycol 5.0
(17) Diisopropanolamine appropriate amount (18) Dipotassium edetate 0.05
(19) Phenoxyethanol 0.02
(20) Purified water remaining amount -------------------------
Total 100.0
Hydrogenated soybean lecithin (***) PC content 60%, acidic phospholipid 20% (vs. PC about 33%)
(調製方法)
1.成分(1)〜(13)を80℃にて、混合、溶解する(a)。
2.成分(15)〜(20)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却後、クリームを得た。
(Preparation method)
1. Components (1) to (13) are mixed and dissolved at 80 ° C. (a).
2. Components (15) to (20) are mixed and dissolved at 80 ° C. (b).
3. (B) was added to (a) and stirred, and after cooling, a cream was obtained.
(参考例32 サンスクリーン)
成分名 配合量(質量%)
(1)エタノール 8.0
(2)微粒子酸化チタン 5.0
(3)酸化亜鉛 5.0
(4)メトキシケイ皮酸オクチル 2.0
(5)POE/POP(*1) 変性ジメチルポリシロキサン 1.0
(6)1,3−ブチレングリコール 15.0
(7)メチルシクロポリシロキサン 0.5
(8)ジメチルポリシロキサン 0.3
(9)水素添加卵黄レシチン(*) 3.5
(10)ミリスチルアルコール 3.0
(11)メチルパラベン 0.1
(12)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
(*1)ポリオキシエチレン/ポリオキシプロピレン
水素添加卵黄レシチン(*) PC含有量55%、酸性リン脂質11%(対PC約20%)
( Reference Example 32 Sunscreen)
Ingredient name Compounding amount (mass%)
(1) Ethanol 8.0
(2) Fine particle titanium oxide 5.0
(3) Zinc oxide 5.0
(4) Octyl methoxycinnamate 2.0
(5) POE / POP (* 1) Modified dimethylpolysiloxane 1.0
(6) 1,3-butylene glycol 15.0
(7) Methylcyclopolysiloxane 0.5
(8) Dimethylpolysiloxane 0.3
(9) Hydrogenated egg yolk lecithin (*) 3.5
(10) Myristyl alcohol 3.0
(11) Methylparaben 0.1
(12) Purified water remaining amount -----------------------------
Total 100.0
(* 1) Polyoxyethylene / polyoxypropylene hydrogenated egg yolk lecithin (*) PC content 55%, acidic phospholipid 11% (vs. PC about 20%)
(調製方法)
1.成分(4)〜(10)を80℃にて、混合、溶解する(a)。
2.成分(11)〜(12)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却する(c)。
4.(c)に成分(1)〜(3)を添加し、攪拌後、サンスクリーンを得た。
(Preparation method)
1. Components (4) to (10) are mixed and dissolved at 80 ° C. (a).
2. Components (11) to (12) are mixed and dissolved at 80 ° C. (b).
3. (B) is added to (a), stirred and cooled (c).
4). Components (1) to (3) were added to (c), and after stirring, a sunscreen was obtained.
(参考例33 ゲル状美容液)
成分名 配合量(質量%)
(1)水素添加卵黄レシチン(**) 1.2
(2)ステアリルアルコール 0.5
(3)ミリスチルアルコール 0.2
(4)エタノール 8.0
(5)ジプロピレングリコール 7.0
(6)ポリエチレングリコール4000 4.0
(7)キサンタンガム 0.1
(8)メチルセルロース 0.05
(9)エデト酸二カリウム 0.02
(10)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加卵黄レシチン(**) PC含有量85%、酸性リン脂質12%(対PC約14%)
( Reference Example 33 Gel serum)
Ingredient name Compounding amount (mass%)
(1) Hydrogenated egg yolk lecithin (**) 1.2
(2) Stearyl alcohol 0.5
(3) Myristyl alcohol 0.2
(4) Ethanol 8.0
(5) Dipropylene glycol 7.0
(6) Polyethylene glycol 4000 4.0
(7) Xanthan gum 0.1
(8) Methylcellulose 0.05
(9) Dipotassium edetate 0.02
(10) Purified water remaining amount -----------------------------
Total 100.0
Hydrogenated egg yolk lecithin (**) PC content 85%, acidic phospholipid 12% (vs. PC about 14%)
(調製方法)
1.成分(1)〜(5)を60℃に加熱し、均一溶解する(a)。
2.成分(6)〜(10)を混合し、溶解する(b)。
3.(b)に(a)を添加して攪拌し、冷却後、美容液を得た。
(Preparation method)
1. Components (1) to (5) are heated to 60 ° C. and uniformly dissolved (a).
2. Components (6) to (10) are mixed and dissolved (b).
3. (A) was added to (b) and stirred, and after cooling, a serum was obtained.
(参考例34 美白ジェル)
成分名 配合量(質量%)
(1)水素添加大豆レシチン(****) 5.0
(3)セチルアルコール 2.0
(4)ステアリルアルコール 2.0
(5)ベヘニルアルコール 2.0
(6)フィトステロール 0.5
(7)プロピレングリコール 9.0
(8)アスコルビン酸グルコシド 2.0
(9)アルブチン 3.0
(10)ポリエチレングリコール1000 1.0
(11)ソルビトール 3.0
(12)マルチトール 4.0
(13)ジイソプロパノールアミン 適 量
(14)水酸化カリウム 適 量
(15)カルボキシビニルポリマー 0.1
(16)エデト酸二ナトリウム 0.04
(17)グリチルリチン酸ジカリウム 0.1
(18)フェノキシエタノール 0.2
(19)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加大豆レシチン(****) PC含有量75%、酸性リン脂質24%(対PC32%)
( Reference Example 34 Whitening Gel)
Ingredient name Compounding amount (mass%)
(1) Hydrogenated soybean lecithin (****) 5.0
(3) Cetyl alcohol 2.0
(4) Stearyl alcohol 2.0
(5) Behenyl alcohol 2.0
(6) Phytosterol 0.5
(7) Propylene glycol 9.0
(8) Ascorbic acid glucoside 2.0
(9) Arbutin 3.0
(10) Polyethylene glycol 1000 1.0
(11) Sorbitol 3.0
(12) Maltitol 4.0
(13) Diisopropanolamine appropriate amount (14) Potassium hydroxide appropriate amount (15) Carboxyvinyl polymer 0.1
(16) Disodium edetate 0.04
(17) Dipotassium glycyrrhizinate 0.1
(18) Phenoxyethanol 0.2
(19) Purified water remaining amount -----------------------------
Total 100.0
Hydrogenated soybean lecithin (****) PC content 75%, acidic phospholipid 24% (vs PC 32%)
1.成分(1)〜(7)を80℃にて、混合、溶解する(a)。
2.成分(8)〜(19)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却後、美白ジェルを得た。
1. Components (1) to (7) are mixed and dissolved at 80 ° C. (a).
2. Components (8) to (19) are mixed and dissolved at 80 ° C. (b).
3. (B) was added to (a) and stirred, and after cooling, a whitening gel was obtained.
(参考例35 抗老化ジェル)
成分名 配合量(質量%)
(1)水素添加大豆レシチン(*****) 5.0
(3)セチルアルコール 2.0
(4)ステアリルアルコール 2.0
(5)ベヘニルアルコール 2.0
(6)フィトステロール 0.5
(7)パルミチン酸レチノール 0.1
(8)ニコチン酸dl−α−トコフェロール 0.1
(9)ユビデカレノン 0.03
(10)グリセリン 3.0
(11)ポリエチレングリコール600 1.0
(12)ジプロピレングリコール 15.0
(13)ソルビトール 2.0
(14)マルチトール 2.0
(15)ジイソプロパノールアミン 適 量
(16)水酸化カリウム 適 量
(17)カルボキシビニルポリマー 0.1
(18)エデト酸二ナトリウム 0.04
(19)グリチルリチン酸ジカリウム 0.1
(20)フェノキシエタノール 0.2
(21)精製水 残 量
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
計 100.0
水素添加大豆レシチン(*****) PC含有量62.5%、酸性リン脂質20%(対PC32%)
( Reference Example 35 Anti-aging gel)
Ingredient name Compounding amount (mass%)
(1) Hydrogenated soybean lecithin (*****) 5.0
(3) Cetyl alcohol 2.0
(4) Stearyl alcohol 2.0
(5) Behenyl alcohol 2.0
(6) Phytosterol 0.5
(7) Retinol palmitate 0.1
(8) nicotinic acid dl-α-tocopherol 0.1
(9) Ubidecarenone 0.03
(10) Glycerol 3.0
(11) Polyethylene glycol 600 1.0
(12) Dipropylene glycol 15.0
(13) Sorbitol 2.0
(14) Maltitol 2.0
(15) Diisopropanolamine appropriate amount (16) Potassium hydroxide appropriate amount (17) Carboxyvinyl polymer 0.1
(18) Edetate disodium 0.04
(19) Dipotassium glycyrrhizinate 0.1
(20) Phenoxyethanol 0.2
(21) Purified water remaining amount -----------------------------
Total 100.0
Hydrogenated soybean lecithin (*****) PC content 62.5%, acid phospholipid 20% (vs PC 32%)
1.成分(1)〜(12)を80℃にて、混合、溶解する(a)。
2.成分(13)〜(21)を80℃にて、混合、溶解する(b)。
3.(a)に(b)を添加して攪拌し、冷却し、美白ジェルを得た。
1. Components (1) to (12) are mixed and dissolved at 80 ° C. (a).
2. Components (13) to (21) are mixed and dissolved at 80 ° C. (b).
3. (B) was added to (a), stirred and cooled to obtain a whitening gel.
参考例29〜35の化粧料を試料とし、上記最終処方における使用感評価方法及び経日安定性方法による評価試験を行った結果、刺激感、べたつきがなく、しっとり感、柔らかな皮膜感及び経日安定性に優れていた。 The cosmetics of Reference Examples 29 to 35 were used as samples, and as a result of performing an evaluation test using the feeling of use evaluation method and the stability method over time in the above final formulation, there was no irritation, stickiness, moist feeling, soft film feeling and Excellent day stability.
1 水素添加リン脂質のみのDSC曲線(比較例3)
2 水素添加リン脂質:セチルアルコール=3:1のDSC曲線(比較例4)
3 水素添加リン脂質:セチルアルコール=3:2のDSC曲線(比較例5)
4 水素添加リン脂質:セチルアルコール=1:1のDSC曲線(参考例4)
5 水素添加リン脂質:セチルアルコール=1:1.6のDSC曲線(参考例5)
6 水素添加リン脂質:セチルアルコール=1:2のDSC曲線(実施例6)
7 水素添加リン脂質:セチルアルコール=1:3のDSC曲線(実施例8)
1 DSC curve of hydrogenated phospholipid only (Comparative Example 3)
2 Hydrogenated phospholipid: cetyl alcohol = 3: 1 DSC curve (Comparative Example 4)
3 Hydrogenated phospholipid: cetyl alcohol = DSC curve of 3: 2 (Comparative Example 5)
4 Hydrogenated phospholipid: cetyl alcohol = 1: 1 DSC curve ( Reference Example 4)
5 DSC curve of hydrogenated phospholipid: cetyl alcohol = 1: 1.6 ( Reference Example 5)
6 DSC curve of hydrogenated phospholipid: cetyl alcohol = 1: 2 (Example 6)
7 Hydrogenated phospholipid: cetyl alcohol = 1: 3 DSC curve (Example 8)
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006177362A JP5523652B2 (en) | 2006-06-27 | 2006-06-27 | Gel cosmetic and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006177362A JP5523652B2 (en) | 2006-06-27 | 2006-06-27 | Gel cosmetic and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008007430A JP2008007430A (en) | 2008-01-17 |
JP5523652B2 true JP5523652B2 (en) | 2014-06-18 |
Family
ID=39065951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006177362A Active JP5523652B2 (en) | 2006-06-27 | 2006-06-27 | Gel cosmetic and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5523652B2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010043027A (en) * | 2008-08-13 | 2010-02-25 | Kracie Home Products Ltd | Oil-in-water type emulsified cosmetic |
JP5476013B2 (en) * | 2009-03-27 | 2014-04-23 | 株式会社ファンケル | Topical skin preparation |
JP2009269919A (en) * | 2009-06-12 | 2009-11-19 | Kiyoko Nishihara | Cosmetic |
JP2012051872A (en) * | 2010-08-05 | 2012-03-15 | Shiseido Co Ltd | Skin cosmetic |
WO2013048780A1 (en) * | 2011-09-29 | 2013-04-04 | Union Carbide Chemicals & Plastics Technology Llc | Cationic conditioner replacements |
JP2013100305A (en) * | 2011-12-28 | 2013-05-23 | Neige Corporation:Kk | Gel and semi-solid detergent |
JP7203751B2 (en) * | 2017-11-07 | 2023-01-13 | 株式会社 資生堂 | skin cosmetics |
JP6988574B2 (en) * | 2018-03-01 | 2022-01-05 | 日油株式会社 | Aqueous gel cosmetic |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59100466D1 (en) * | 1990-02-08 | 1993-11-11 | Nattermann A & Cie | AQUEOUS GELLY PHOSPHOLIPID COMPOSITION CONTAINING ALCOHOL, ITS USE AND TOPICAL PREPARATIONS THAT CONTAIN IT. |
JP3159622B2 (en) * | 1995-03-23 | 2001-04-23 | 日清製油株式会社 | Cosmetic or external preparation containing humectant composition |
US20040247678A1 (en) * | 2001-11-09 | 2004-12-09 | Ryoichi Toyoda | Gel-form composition |
DE10255285A1 (en) * | 2002-11-26 | 2004-06-03 | Mcs Micro Carrier Systems Gmbh | Self-forming phospholipid gels |
JP2004346039A (en) * | 2003-05-23 | 2004-12-09 | Treasure Jp Inc | Emulsified composition |
JP4731109B2 (en) * | 2003-10-31 | 2011-07-20 | 株式会社 資生堂 | Gel composition and cream composition using the same |
-
2006
- 2006-06-27 JP JP2006177362A patent/JP5523652B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008007430A (en) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5523652B2 (en) | Gel cosmetic and method for producing the same | |
JP2010043027A (en) | Oil-in-water type emulsified cosmetic | |
WO2005051334A1 (en) | Oil-in-water-type emulsified cosmetic preparation and process for producing the same | |
JP2011195455A (en) | Cosmetic | |
JP2013067580A (en) | Wrinkle improving cosmetic | |
JP3524501B2 (en) | Cosmetics | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP2008044901A (en) | Oil-in-water type makeup cosmetic | |
JP7129768B2 (en) | surface treatment powder | |
JP2014101344A (en) | Cosmetic | |
JP2007008840A (en) | Cosmetic | |
JP6208476B2 (en) | Oil-in-water cosmetic | |
JP6367003B2 (en) | Oil-in-water emulsified cosmetic | |
JP2004091360A (en) | Cosmetic | |
JP2006282603A (en) | Cosmetic product | |
JP2018035127A (en) | Oil-in-water cosmetics | |
JP4666792B2 (en) | Cosmetics | |
KR101893776B1 (en) | Cosmetic composition comprising of oleanolic acid and salvianolic acid for improving skin whitening or skin wrinkle | |
JP2012201683A (en) | Cosmetic | |
JP6986329B2 (en) | Wrinkle-relieving skin cleanser | |
JP2003095844A (en) | Cosmetic | |
JPH10245317A (en) | W/o-type emulsion composition | |
JP2005002078A (en) | Water-based liquid cosmetic | |
JP3442698B2 (en) | Manufacturing method of cosmetics | |
JP2011026273A (en) | Cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081208 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110411 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110706 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110831 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110905 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111003 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120425 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120725 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120920 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20121012 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140409 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5523652 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |